Back to Search
NICHOLAS JAMES, PHARMD
PHARMD
Pharmacist
NPI: 1730516493Individual
Specialties, Licenses & Credentials
Pharmacist Clinician (PhC)/ Clinical Pharmacy Specialist
Pharmacist — Pharmacist Clinician (PhC)/ Clinical Pharmacy Specialist
Code: 1835P0018X
13774(OR)
PharmacistPrimary
Pharmacist
Code: 183500000X
0013774(OR)
Research & Publications (20)
Systemic therapy for advancing or metastatic prostate cancer (STAMPEDE): a multi-arm, multistage randomized controlled trial.
PMID 18990168·BJU Int·2009
3-trial
The changing pattern of management for hormone-refractory, metastatic prostate cancer.
PMID 16801939·Prostate Cancer Prostatic Dis·2006
6-review
The development of position-specific performance indicators in professional rugby union.
PMID 15841596·J Sports Sci·2005
8-other
Management of muscle invasive bladder cancer--British approaches to organ conservation.
PMID 15662603·Semin Radiat Oncol·2005
6-review
A national audit of radiotherapy in head and neck cancer.
PMID 12708709·Clin Oncol (R Coll Radiol)·2003
8-other
Surface thiocyanation of plasticized poly(vinyl chloride) and its effect on bacterial adhesion.
PMID 12699656·Biomaterials·2003
4-observational
Evaluation of hemolysis in the VentrAssist implantable rotary blood pump.
PMID 12534722·Artif Organs·2003
4-observational
A phase II study of the bispecific antibody MDX-H210 (anti-HER2 x CD64) with GM-CSF in HER2+ advanced prostate cancer.
PMID 11461069·Br J Cancer·2001
3-trial
Inequivalent contribution of the five tryptophan residues in the C-lobe of human serum transferrin to the fluorescence increase when iron is released.
PMID 19281173·Biochemistry·2009
8-other
In vitro and in vivo anticancer effects of the novel vitamin E ether analogue RRR-alpha-tocopheryloxybutyl sulfonic acid in prostate cancer.
PMID 19188160·Clin Cancer Res·2009
7-preclinical
Safety and efficacy of the specific endothelin-A receptor antagonist ZD4054 in patients with hormone-resistant prostate cancer and bone metastases who were pain free or mildly symptomatic: a double-blind, placebo-controlled, randomised, phase 2 trial.
PMID 19042080·Eur Urol·2009
3-trial
Incorporation of 5-hydroxytryptophan into transferrin and its receptor allows assignment of the pH induced changes in intrinsic fluorescence when iron is released.
PMID 19103311·Biochim Biophys Acta·2009
8-other
Sorafenib induces therapeutic response in a patient with metastatic collecting duct carcinoma of kidney.
PMID 19209019·Onkologie·2009
5-case
A phase I/II clinical trial in localized prostate cancer of an adenovirus expressing nitroreductase with CB1954 [correction of CB1984].
PMID 19367257·Mol Ther·2009
3-trial
Structural and functional consequences of the substitution of glycine 65 with arginine in the N-lobe of human transferrin.
PMID 19219998·Biochemistry·2009
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 12575 SW WALKER RD
BEAVERTON, OR 97005 - Phone
- (503) 646-2423
Quick Facts
- NPI
- 1730516493
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 2
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile